Metagenes Associated with Survival in Non-Small Cell Lung Cancer

NSCLC (non-small cell lung cancer) comprises about 80% of all lung cancer cases worldwide. Surgery is most effective treatment for patients with early-stage disease. However, 30%–55% of these patients develop recurrence within 5 years. Therefore, markers that can be used to accurately classify early...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Urgard, Egon, Vooder, Tõnu, Võsa, Urmo, Välk, Kristjan, Liu, Mingming, Luo, Cheng, Hoti, Fabian, Roosipuu, Retlav, Annilo, Tarmo, Laine, Jukka, Frenz, Christopher M., Zhang, Liqing, Metspalu, Andres
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Libertas Academica 2011
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3118451/
https://ncbi.nlm.nih.gov/pubmed/21695068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CIN.S7135
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia